BI-1701963

N/A

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameBI-1701963
Drug Alias NameBI-1701963
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitorsSon of sevenless homolog 1 inhibitors
TargetsGTPase KRasSon of sevenless homolog 1
Therapy Area/IndicationsSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsGermany +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesForma Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Inactive CompaniesBoehringer Ingelheim International GmbhBoehringer Ingelheim (China) Investment Co Ltd
Active IndicationsSolid tumours
Inactive IndicationsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A